KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $11.2 billion.

  • Biogen's Total Liabilities fell 132.88% to $11.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.2 billion, marking a year-over-year decrease of 132.88%. This contributed to the annual value of $11.2 billion for FY2025, which is 132.88% down from last year.
  • Per Biogen's latest filing, its Total Liabilities stood at $11.2 billion for Q4 2025, which was down 132.88% from $11.0 billion recorded in Q3 2025.
  • Biogen's Total Liabilities' 5-year high stood at $13.7 billion during Q3 2023, with a 5-year trough of $10.7 billion in Q2 2025.
  • For the 5-year period, Biogen's Total Liabilities averaged around $11.9 billion, with its median value being $11.7 billion (2024).
  • Over the last 5 years, Biogen's Total Liabilities had its largest YoY gain of 1345.29% in 2023, and its largest YoY loss of 1907.78% in 2023.
  • Over the past 5 years, Biogen's Total Liabilities (Quarter) stood at $12.9 billion in 2021, then dropped by 13.56% to $11.2 billion in 2022, then grew by 7.88% to $12.0 billion in 2023, then decreased by 5.91% to $11.3 billion in 2024, then fell by 1.33% to $11.2 billion in 2025.
  • Its Total Liabilities was $11.2 billion in Q4 2025, compared to $11.0 billion in Q3 2025 and $10.7 billion in Q2 2025.